Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Luz García Vivar"'
Autor:
Concepción Delgado Beltrán, Isabel Castrejón, Blanca Hernández-Cruz, Maria Luz García Vivar, Rosario García de Vicuña, Montserrat Romera Baures, Patricia Carreira, Esperanza Naredo, Delia Reina, María Galindo, Cilia Peralta, Blanca Varas de Dios, Loreto Carmona
Publikováno v:
Reumatología Clínica (English Edition).
Autor:
Antonio Escobar, Juan Ramon De Dios, I. Gorostiza, Ainhoa Ruiz del Agua, J. Belzunegui, Ziortza Trancho, Ana Ruibal-Escribano, Lorena del Rio, Cristina Jorquera, Margarida Vasques, Eduardo Úcar, Antonio Pérez Martínez, Clara Pérez, Catalina Gomez-Arango, Eli Diez, C. Stoye, Belen Alvarez, Daniel Nagore, Maria Luz García-Vivar
Publikováno v:
Rheumatology and Therapy
Introduction To assess the clinical and cost-effectiveness of therapeutic drug monitoring (TDM) based on serum adalimumab levels compared to standard of care in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Metho
Autor:
Santos Castañeda, Ricardo Blanco, Clementina López-Medina, Miguel A González-Gay, Fernanda Genre, Diana Peiteado, Vanesa Calvo-Río, Elena Aurrecoechea, Chamaida Plasencia-Rodríguez, Carlos Rodríguez-Lozano, Cristina Fernández-Carballido, Javier Rueda-Gotor, Juan Carlos Quevedo-Abeledo, Esther F Vicente-Rabaneda, Lourdes Ladehesa-Pineda, Eva Galíndez-Agirregoikoa, Ivan Ferraz-Amaro, Virginia Portilla, Rosa Expósito, Cristina Corrales-Selaya, Ricardo Batanero, Vanesa Hernández-Hernández., María Paz Martínez Vidal, David Castro Corredor, Joaquín Anino Fernández, Maria Luz Garcia Vivar, Nuria Vegas, Irati Urionagüena, Esther Montes-Perez
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Introduction The nature of the relationship between inflammation, cardiovascular (CV) risk factors and atherosclerosis in axial spondyloarthritis (axSpA) remains largely unknown and sex differences in this regard are yet to be assessed.Methods Study
Externí odkaz:
https://doaj.org/article/692692bd25e84d3199b2daeb8440af5f
Autor:
Iván Ferraz-Amaro, Javier Rueda-Gotor, Fernanda Genre, Alfonso Corrales, Ricardo Blanco, Virginia Portilla, Iñigo González Mazón, Javier Llorca, Rosa Expósito, Esther F. Vicente, Juan Carlos Quevedo-Abeledo, Carlos Rodríguez-Lozano, Rafaela Ortega-Castro, María Lourdes Ladehesa-Pineda, Cristina Fernández-Carballido, M Paz Martínez-Vidal, David Castro-Corredor, Joaquín Anino-Fernández, María Luz García Vivar, Eva Galíndez-Agirregoikoa, Diana Peiteado, Chamaida Plasencia-Rodríguez, Esther Montes Perez, Carlos Fernández Díaz, Santos Castañeda, Miguel Ángel González-Gay
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Background: Axial spondyloarthritis (axSpA) patients are known to have a higher prevalence of several comorbidities, including, among others, an increased risk of atherosclerosis, hypertension, dyslipidemia, and diabetes. The purpose of the present s
Externí odkaz:
https://doaj.org/article/672816766f9c48df97062a14e1236fb5